SCHEMBL21929205

SCHEMBL21929205

N#Cc1cccc(-c2c(-n3c4ccc(-c5ccccc5C#N)cc4c4cc(-c5ccccc5C#N)ccc43)cncc2-n2c3ccc(-c4ccccc4C#N)cc3c3cc(-c4ccccc4C#N)ccc32)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2B Q13224 1/20 0.40
GABRG2 P18507 7/20 0.40
GABRB3 P28472 7/20 0.40
GABRA1 P14867 6/20 0.40
GABRA5 P31644 5/20 0.40
GABRA3 P34903 5/20 0.40
GABRA2 P47869 4/20 0.40
CYP19A1 P11511 1/20 0.39
TRPA1 O75762 1/20 0.39
CYP1A2 P05177 5/20 0.39
CYP3A4 P08684 5/20 0.39
HSD17B10 Q99714 4/20 0.39
HPGD P15428 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24737368 0.97 TRPA1 (0.39) NR3C1GRIN1GRIN2BGABRG2GABRB3
SCHEMBL24737231 0.93 GRIN1 (0.42) NR3C1GRIN1GRIN2BGABRG2GABRB3
SCHEMBL24737371 0.92 GRIN1 (0.42) NR3C1GRIN1GRIN2BGABRG2GABRB3
SCHEMBL24737370 0.92 GRIN1 (0.40) NR3C1GRIN1GRIN2BGABRG2GABRB3
SCHEMBL21929234 0.91 PRMT5 (0.39) GRIN1GRIN2BCYP1A2CYP3A4HSD17B10
SCHEMBL24738579 0.91 NR3C1 (0.42) NR3C1GABRG2GABRB3GABRA1GABRA5
SCHEMBL24737222 0.90 GRIN1 (0.41) NR3C1GRIN1GRIN2BGABRG2GABRB3
SCHEMBL21546579 0.90 ADRA2C (0.40) NR3C1GRIN1GRIN2BGABRG2GABRB3
SCHEMBL21928424 0.89 PRMT5 (0.37) GRIN1GRIN2BCYP1A2CYP3A4HSD17B10
SCHEMBL21931843 0.88 NR3C1 (0.45) NR3C1GABRG2GABRB3GABRA1GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 NR3C1 2039/4885GRIN1 1963/4885GRIN2B 766/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA NR3C1 3420/4885GRIN1 1178/4885GRIN2B 290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.